Dual JAK Inhibition Demonstrates Efficacy in Progressive Nonsegmental Vitiligo

A recent study highlighted the potential of combining oral upadacitinib with topical ruxolitinib cream as a safe and effective therapeutic strategy for patients with progressive nonsegmental vitiligo (NSV). The findings, published in JAAD…